HIPEC – updated recommendations

Last week, Friday, 20.01.2023, the presentation of the updated recommendations on the technique of tumor cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC), indicated for peritoneal carcinomatosis of colorectal, gastric, ovarian origin, as well as for peritoneal pseudomyxoma and malignant mesothelioma, took place online. It was the result of colossal work carried out by colleagues from European centres of excellence in the field, with the aim of homogenising practice, optimising results and indicating future lines of research in the field. Sincere thanks for this effort!
Our team ensures that you follow consensus guidelines to maintain the quality of treatment for patients with peritoneal metastases and to align standards and outcomes with centres of excellence around the world.